DEMG — Deltex Medical Cashflow Statement
0.000.00%
Last trade - 00:00
- £2.18m
- £4.29m
- £2.48m
- 18
- 44
- 14
- 14
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.34 | -0.21 | -0.794 | -0.978 | -1.15 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.253 | 0.255 | 0.308 | 0.266 | 0.359 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.652 | 0.331 | 0.275 | 0.307 | 0.053 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.32 | 0.609 | -0.068 | -0.291 | -0.606 |
Capital Expenditures | -0.232 | -0.26 | -0.171 | -0.644 | -0.744 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.018 | 0.059 | 0 | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.214 | -0.201 | -0.171 | -0.644 | -0.744 |
Financing Cash Flow Items | -0.132 | 0 | -0.003 | 0.5 | 0.135 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.88 | -0.067 | 0.19 | 0.502 | 1.41 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.361 | 0.328 | -0.055 | -0.44 | 0.058 |